In that context, chemotherapy treatment of ovarian cancer cells in which TIMP-2 was knocked down failed to activate Stat3, implying that TIMP-2 and Stat3 may be critical regulators of chemoresistance (38). Here, STAT3 is linked to ovarian carcinoma.